BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38131251)

  • 1. Ursolic acid inhibits the metastasis of colon cancer by downregulating ARL4C expression.
    Zhang M; Xiang F; Sun Y; Liu R; Li Q; Gu Q; Kang X; Wu R
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway.
    Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F
    Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells.
    Sun Y; Zhang Z; Xiang F; Zhang M; Chen Q; Tang L; Zhu L; Liu J; Meng Z; Hu J; Luo X; Ni Z; Wang X
    Life Sci; 2020 Apr; 246():117428. PubMed ID: 32057901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway.
    Wang EM; Fan QL; Yue Y; Xu L
    Med Sci Monit; 2018 Feb; 24():846-854. PubMed ID: 29428962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
    Xiao W; Liu Y; Dai M; Li Y; Peng R; Yu S; Liu H
    Int J Mol Med; 2020 Aug; 46(2):700-708. PubMed ID: 32626924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of petasin on human colon carcinoma cells mediated by inactivation of Akt/mTOR pathway.
    Lyu X; Song AL; Bai YL; Xu XD; He DQ; Zhang YC
    Chin Med J (Engl); 2019 May; 132(9):1071-1078. PubMed ID: 30896562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
    Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
    Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells.
    Wang J; Liu L; Qiu H; Zhang X; Guo W; Chen W; Tian Y; Fu L; Shi D; Cheng J; Huang W; Deng W
    PLoS One; 2013; 8(5):e63872. PubMed ID: 23737956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling.
    Yeh CT; Wu CH; Yen GC
    Mol Nutr Food Res; 2010 Sep; 54(9):1285-95. PubMed ID: 20352621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth.
    Harada T; Matsumoto S; Hirota S; Kimura H; Fujii S; Kasahara Y; Gon H; Yoshida T; Itoh T; Haraguchi N; Mizushima T; Noda T; Eguchi H; Nojima S; Morii E; Fukumoto T; Obika S; Kikuchi A
    Mol Cancer Ther; 2019 Mar; 18(3):602-612. PubMed ID: 30647122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
    Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
    Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic acid induces U937 cells differentiation by PI3K/Akt pathway activation.
    Deng L; Zhang R; Tang F; Li C; Xing YY; Xi T
    Chin J Nat Med; 2014 Jan; 12(1):15-9. PubMed ID: 24484591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.
    Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L
    PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
    Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
    J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.